Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in CDXS — Codexis, Inc.

CIK 1362033 LONDON, X0
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$94,492
-$96,092 QoQ
Shares Held
41,811
-64.2% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 148 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. CDXS ranks #145 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 655,318 $2,726,122
2 IMVT
Immunovant, Inc.
 65,267 $2,514,737
3 GOSS
Gossamer Bio, Inc.
 187,337 $2,472,846
4 AXSM
Axsome Therapeutics, Inc.
 9,419 $2,305,488
5 CABA
Cabaletta Bio, Inc.
 668,563 $2,079,230
6 MLTX
MoonLake Immunotherapeutics
 106,695 $2,077,351
7 ATYR
aTYR PHARMA INC
 3,454,863 $2,062,553
8 CORT
Corcept Therapeutics Inc
 23,257 $2,022,196

All Filings in CDXS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $94,492 41,811
2026-03-31 $190,584 116,923
2024-09-30 $306,857 99,629
2024-06-30 $168,305 54,292
2024-03-31 $173,208 49,630
2023-12-31 $2,552,959 837,036
2023-09-30 $786,351 416,059
2023-03-31 $667,330 161,191
2022-12-31 $617,785 132,572
2022-09-30 $863,004 142,410
2022-06-30 $640,905 61,272
2021-09-30 $624,344 26,842
2021-06-30 $653,333 28,832
2021-03-31 $368,460 16,097
2020-09-30 $131,030 11,161